Hui-qi Dai

Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy

Guo-Dong Lu, S. Hooi, Liming Wang, 2022, Experimental & Molecular Medicine.

Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Guo-Dong Lu, Zi-Xuan Wang, Jing Zhou, 2020, Frontiers in Pharmacology.

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma

Yuehua Wu, Guo-Dong Lu, Xiao-Mei Yang, 2020, Acta Pharmacologica Sinica.

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma

Guo-Dong Lu, Ji Feng, Yong Wu, 2020, Acta Pharmacologica Sinica.

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma

Yuehua Wu, Guo-Dong Lu, Jing Zhou, 2020, Acta Pharmacologica Sinica.

Histone deacetylases up-regulate C/EBPα expression through reduction of miR-124-3p and miR-25 in hepatocellular carcinoma.

Guo-Dong Lu, S. Hooi, Zi-Xuan Wang, 2019, Biochemical and biophysical research communications.

Distinct effects of anti-diabetic medications on liver cancer risk and patient survival.

Jing Zhou, Yong Wu, Yao Chen, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

promotes non-small cell lung cancer progression by activating the Wnt/β-catenin pathway

Xiaoying Wu, Yuefeng Zhang, Sunshun Yan, 2020 .

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma

Guo-Dong Lu, Yu-jia Liu, Ji Feng, 2020, Acta Pharmacologica Sinica.